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Abstract
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) may represent a serious public health problem, owing to the
spread of toxin-producing lineages. The presence of genes encoding for Panton–Valentine leukocidin (PVL) is an important virulence
marker, as the clinical sequelae of PVL-positive infections are often described as more severe than those of PVL-negative S. aureus infections.
To date, the presence of PVL has not appeared to be common in Italy; we describe the intrafamilial transmission of an epidemic
PVL-producing CA-MRSA lineage, Southwest Paciﬁc clone (SWP). Our data suggested that the strain circulated from the father, who was
recurrently affected by a soft tissue infection, to the mother, who showed nasal colonization, and to their child, who was hospitalized with
symptoms of necrotizing pneumonia. In this case, we found that a recurrent skin infection that is not normally taken into account may
represent a serious threat if caused by a PVL-producing strain. Our ﬁndings may have considerable implications for strategies for infection
control and treatment of methicillin-resistant S. aureus infections.
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Currently, methicillin-resistant Staphylococcus aureus (MRSA) is
one of the most frequently isolated pathogens, especially in
clinical settings. Since its discovery, MRSA has been found to
develop antimicrobial resistance extremely rapidly. In the early
1940s, before the introduction of penicillin and the treatment
of S. aureus infections with this antibiotic, the mortality rate of
patients with S. aureus infection was approximately 80% [1].
A few years later, penicillin was introduced for medical
purposes, and penicillin-resistant strains emerged, ﬁrst in
clinical settings and then in the community. The progressive
introduction of new antimicrobial agents has been a powerful
factor triggering MRSA to develop resistance mechanisms. The
acquisition of mecA generated the ﬁrst MRSA strain [1]. This
gene is located in a genetic determinant named staphylococcal
chromosome cassette mec (SCCmec). Several types of
SCCmec have been distinguished, from I to XI, differing in
size and content [2]. Some cassettes can confer resistance to
b-lactam antibiotics only; some others are able to confer
multiple resistance determinants, owing to integrated plasmids
or transposons [1]. The original criteria for distinguishing
between hospital-acquired and community-acquired infections
were suggested by the CDC, and were based on a deﬁned
group of risk factors, such as hospitalization, invasive clinical
practices, and staying in long-term-care facilities [1]. From the
late 1990s, many reports appeared concerning MRSA coloni-
zation and infection involving patients lacking the previously
described risk factors. Community-acquired MRSA
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(CA-MRSA) clones were spreading worldwide. Recently,
CA-MRSA has started to replace hospital-acquired MRSA
(HA-MRSA) in hospital settings, especially in areas with a high
prevalence of CA-MRSA [1].
On the basis of the differences in SCCmec genomic islands,
it was possible to deﬁne differences between CA-MRSA and
HA-MRSA [1], and to obtain a likely picture of MRSA
epidemiology. CA-MRSA strains are usually characterized by
a smaller SCCmec genomic island than HA-MRSA, and a
different genetic background: CA-MRSA strains belong to
unrelated clonal types [1].
Different sizes of SCCmec elements between CA-MRSA
and HA-MRSA correspond to different antimicrobial resis-
tance patterns; HA-MRSA strains are more often multi-
drug-resistant than are CA-MRSA strains, which tend to be
more virulent [3]. CA-MRSA can cause a wide range of
diseases, from soft tissue infections to highly invasive necro-
tizing pneumonia, severe sepsis, and necrotizing fasciitis [3], as
a consequence of its wide repertoire of transferable toxin
genes. Among this plethora of genes, those encoding Panton–
Valentine leukocidin (PVL) constitute the most consistently
present transferable toxin locus in CA-MRSA. PVL is a
bi-component pore-forming leukotoxin that was associated
with skin and soft tissue infections in 1932 by Panton and
Valentine [3]. This toxin is encoded by two contiguous and
co-transcribed genes, lukF-PV and lukS-PV, which reside in the
genomes of several different temperate bacteriophages [4].
Inﬁltration of such bacteriophages in different lineages of
MRSA caused the spread of a polyclonal population of
CA-MRSA producing PVL [4]. Several sequence types (STs)
of PVL-positive MRSA are known, and some of these strains
occur and predominate in certain regions [5], such as USA300
in North America, and ST30-MRSA-IV, South West Paciﬁc
clone (SWP) in South America. Moreover, different PVL-po-
sitive clones were recently described as ST88 and ST1820 in
Tanzania [6], and ST152-MRSA-V or Balkan clone [8] in Serbia.
SWP was deﬁned as ubiquitous because of its wide distribution
all over the world [7,9–12]. This particular clone has been
reported to be responsible for mild and severe infections in
Brazil [12,13,32], and also in Europe [2,14].
Strains and Methods
Bacterial strains
A 3-month-old Brazilian child was admitted to hospital because
of respiratory distress and poor feeding. He was affected by
necrotizing pneumonia with pyopneumothorax, and a pleural
drain was positioned. Parental nasal swabs were collected for
infection control purposes.
Bacterial culture and biochemical identiﬁcation
Pleural drainage specimens and parental nasal samples were
cultured by inoculating plates of agar selective for S. aureus
(Mannitol Salt 2 Agar; bioMerieux, Marcy L’Etoile, France), and
three strains were obtained, one from each sample. To
conﬁrm the species-level identiﬁcation, the Slidex Staph Plus
(Bio-Rad, Hercules, CA, USA) test was performed, and strains
were identiﬁed with Vitek (Vitek 2; bioMerieux).
Antimicrobial susceptibility testing
The three strains obtained by culture were tested with Vitek
(Vitek 2; bioMerieux), using a P580card. Antimicrobial sus-
ceptibility patterns were determined according to the CLSI
recommendations [15]. A panel of antimicrobial agents was
tested, including: oxacillin, penicillin G, vancomycin, teicopla-
nin, linezolid, gentamicin, tobramycin, norﬂoxacin, levoﬂoxa-
cin, moxiﬂoxacin, erythromycin, clindamycin, tetracycline,
rifampicin, fosfomycin, mupirocin, fusidic acid, trimethoprim–
sulphamethoxazole, and nitrofurantoin. Susceptibility to gly-
copeptides was evaluated with the Etest macromethod.
Intraspecies genotyping
DNA extraction was performed according to the manufac-
turer’s instructions with a Nucleo Spin Tissue kit (Mache-
rey-Nagel, D€uren, Germany), with lysostaphin at 0.5 mg/mL
for the lysis step. The ﬁrst typing method that we used to
assess strain sharing was ERIC-PCR, performed according to
the method of Struelens et al. [16].
SCCmec typing
The structure of the SCCmec element was determined with
the multiplex PCR strategy developed by Oliveira and de
Lancastre in 2002 [17].
PVL testing
The presence of lukF-PV and lukS-PV was tested by means of
PCR, according to the protocol of Lina et al. [18].
Multilocus sequence typing (MLST)
MLST analysis was performed as previously described [19], and
STs were attributed by submitting the DNA sequences
obtained to the online MLST database (http://www.mlst.net/).
Results
The ﬁrst MRSA strain isolated was from a 3-month-old child
from Brazil, and living in Italy with his Brazilian family. The
infant was previously healthy, and was admitted to hospital
because of respiratory distress and poor feeding; he was
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started on ampicillin–sulbactam and gentamicin after blood test
results suggestive of infection had been obtained. A pleural
drain was positioned, from which we were able to isolate an
MRSA strain. Parental nasal swabs were collected to highlight
the presence of MRSA, both giving positive results. All of these
isolates—the one from the pleural drain and the nasal strains
from parental specimens—showed the same antimicrobial
susceptibility patterns and the same MIC values, each strain
being resistant to b-lactams only, as shown in Table 1.
The presence of genes encoding for PVL was tested by
means of PCR, and lukF-PV and lukS-PV were found in all three
isolates. A PCR assay to highlight DNA ﬁngerprint similarities
was performed as a ﬁrst step of intraspecies typing, with the
random primers ERIC1R and ERIC2 [16]. All isolates matched
as a unique genotype, as shown in Fig. 1.
Subsequently, we tested these three isolates to determine
which SCCmec and ST they belonged to: SCCmec typing and
MLST analysis allowed us to ascribe all isolates to SWP,
characterized by SCCmec type IV and ST30.
Discussion
A report by Huijsdens et al. demonstrated that family mem-
bers can serve as reservoirs of PVL-positive MRSA and that
transmission can occur among them [20]. Perez-Roth et al.
recently showed that soft tissue infections can be caused by
PVL-positive methicillin-sensitive S. aureus belonging to ST152
and shared by different members of the same family [21]. Our
recent ﬁnding of an entire family sharing the same SWP strain,
one of the ancient CA-MRSA lineages, indicates a worrying
possibility of intrafamilial transmission of an already described
epidemic clone. In the past few years, isolation of CA-MRSA
has been more frequent, especially in geographical areas with a
high prevalence, where these strains have also started to
replace HA-MRSA in hospital settings [1]. Because of its
virulence, CA-MRSA could be a serious public health problem.
In particular, the presence of PVL is an important virulence
marker. The clinical sequelae of PVL-positive infections are
often described as more severe than those of PVL-negative
infections [3]. PVL-positive CA-MRSA can be ascribed to six
different genetic lineages [10], to which the presence of PVL
genes may have conferred better ﬁtness. Moreover, it is
known that the genetic backgrounds of CA-MRSA strains are
distinct in different geographical locations, and that different
genetic backgrounds can exist within a small area [3]. In
Europe, the most frequently isolated CA-MRSA clones are
USA300-related and European clone-related, and SWP
appears to be sporadically present, as is the Queensland clone
(ST93-MRSA-IV) [2]. Concerning PVL producers, the most
prevalent CA-MRSA clones are ST80 in Europe, USA300 in the
USA, and the ubiquitous SWP. The last of these has been
recognized as being responsible for severe infections
[13,22,23], as well as intrafamilial transmission [10,22,24–27].
Maternal carriage may cause infant colonization, but this
hypothesis has been rarely tested so far [24]. A recent study
TABLE 1. Antimicrobial susceptibility proﬁles of methicil-












Clindamycin  0.25  0.25  0.25
Erythromycin  0.25  0.25  0.25
Fosfomycin  8  8  8
Fusidic acid  0.5  0.5  0.5
Gentamicin  0.5  0.5  0.5
Levoﬂoxacin  0.12  0.12  0.12
Linezolid 2 2 2
Moxiﬂoxacin  0.25  0.25  0.25
Mupirocin  2  2  2
Oxacillin 1 1 1
Rifampicin  0.5  0.5  0.5
Tigecycline  0.12  0.12  0.12
Trimethoprim
–sulphamethoxazole
 10  10  10
Vancomycin 0.5 0.5 0.5
Penicillin G  0.5  0.5  0.5
Tobramycin  1  1  1
Teicoplanin 0.38 0.38 0.38
Tetracycline  1  1  1
Nitrofurantoin  16  16  16
FIG. 1. Intraspecies genotyping of methicillin-resistant Staphylococcus
aureus (MRSA) from three family members. Lane L: DNA ladder, a
mixture of DNA ladders XIII and XIV (Roche Diagnostics, Basel,
Switzerland). Lanes 1–3: MRSA from son’s pleural drainage, father’s
nasal swab, and mother’s nasal swab, respectively; ERIC1R primer.
Lanes 4–6: MRSA from son’s pleural drainage, father’s nasal swab, and
mother’s nasal swab, respectively; ERIC2 primer.
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pointed out that colonized mothers shared their strains with
children during the ﬁrst months after birth and, interestingly,
one of the most frequent clones was SWP [24]. In this
particular case, the child’s father had a previous history of
recurrent furuncles, allowing the hypothesis that he was the
ﬁrst member of the family to be infected. The mother tested
positive for nasal colonization, and the strain found was the
same as that in her husband and child, as shown by both
ERIC-PCR and MLST and SCCmec typing, suggesting that she
may have transmitted the infection to her son.
The ﬁrst step used to compare DNA ﬁngerprints was a
rapid method that we chose to assess the presence of a shared
genotype. Although this method is less discriminative than
pulsed-ﬁeld gel electrophoresis [16], in these particular
circumstances it was a reliable and robust ﬁrst screening tool.
The need to test strains that were strongly suspected of
belonging to the same clone, as suggested by antimicrobial
susceptibility patterns and the presence of PVL, led us to apply
this DNA ﬁngerprinting method to conﬁrm this suspicion. At
the same time, these three strains were tested by means of
SCCmec typing and MLST, to complete the genotyping, and
this analysis highlighted the presence of the already described
epidemic clone. We found that all MRSA isolates from samples
of the members of this family belong to SWP, which is often
described as a ubiquitous MRSA PVL-producing strain, with
diffusion especially in Asia and South America. Recent reports
have described the Italian situation with regard to CA-MRSA
diffusion [28–31]. Sanchini et al. collected 18 strains from all
over Italy, and showed that the most frequent clone was
USA300, but only one of these tested positive for PVL [28]. In
the northern part of Italy, SWP was recently described in
unrelated infectious episodes [29]. In the southern part of Italy,
recent reports indicate that different CA-MRSA lineages are
well represented in Palermo [30,31]. To date, the presence of
PVL does not appear to be common in Italy, but the
distribution of this peculiar virulence factor in the community
should be adequately investigated. Our description of the
intrafamilial transmission of an epidemic PVL-positive
CA-MRSA clone is one of a few cases that have been
described [28,29,31]. Interestingly, this family originated from
Brazil, an area endemic for SWP, as well as for other clones,
such as USA300 and USA400 [32], suggesting direct impor-
tation of this infectious agent. This is important for under-
standing the changing picture of MRSA epidemiology, strain
migration, and the replacement of different clones in different
areas. Moreover, it is important to note that a recurrent skin
infection that is normally not taken into account may be a
serious threat when caused by a PVL-producing strain. The
importance of correct antimicrobial treatment of a soft tissue
recurrent infection is clear, as the ﬁrst infected patient was
able to transmit the same strain to the infant, with a more
severe clinical onset. It has been reported that some individ-
uals are more likely to be carriers than others, so under-
standing the type of strain that they harbour may be important
for the development of decontamination strategies [33]. More
aggressive decolonization may be suggested for PVL-producing
infecting strains. These data may have considerable implications
for strategies for infection control and the treatment of MRSA
infections. In particular, this intrafamilial transmission suggests
the need for more careful molecular surveillance of staphylo-
coccal infections and subsequent antimicrobial treatment.
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